Literature DB >> 10359896

Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes.

S E Burastero1, Z Magnani, C Confetti, L Abbruzzese, S Oddera, P Balbo, G A Rossi, E Crimi.   

Abstract

BACKGROUND: Alveolar macrophages (AMs) are more efficient antigen-presenting cells in allergic individuals than in nonatopic subjects.
OBJECTIVE: We studied whether this difference may be correlated to increased expression of membrane costimulatory molecules, such as the B7 molecules (CD80 and CD86).
METHODS: Eleven subjects with allergic asthma sensitized to Dermatophagoides pteronyssinus and 5 healthy nonatopic volunteers underwent bronchoalveolar lavage, and the costimulatory molecule expression on AMs was evaluated. Peripheral blood T cells, either freshly isolated or as established D pteronyssinus -specific cell lines, were cultured with autologous monocytes or AMs as antigen-presenting cells. In vitro allergen-induced proliferation and cytokine production were evaluated in the presence of B7-blocking reagents.
RESULTS: Allergic individuals had a significantly higher proportion of AMs expressing the CD80 molecule than control subjects (28.5% +/- 14.8% vs 1.4% +/- 1.2%; P <.001), whereas no difference was observed in CD86 expression (2.0% +/- 2.3% vs 1.1% +/- 0.6; P >.1). In a large proportion of the asthmatic subjects we studied, AMs were presenting soluble antigens (tetanus toxoid and streptolysin-O) to freshly isolated T cells more efficiently than AMs from nonatopic control subjects. Finally, both T-cell proliferation and cytokine production of D pteronyssinus- specific established T-cell lines were inhibited by a CD80-blocking antibody in a dose-dependent manner.
CONCLUSION: Costimulation by means of CD80 expressed by AMs is probably involved in the amplification of the allergen-specific T-lymphocyte response in the airways of asthmatic subjects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359896     DOI: 10.1016/s0091-6749(99)70189-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

1.  Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma.

Authors:  C K Wong; S W M Lun; F W S Ko; W K Ip; D S C Hui; C W K Lam
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

2.  Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2.

Authors:  G Ménard; V Turmel; E Y Bissonnette
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

Review 3.  The role of costimulatory molecules in allergic disease and asthma.

Authors:  Vincent Lombardi; Abinav K Singh; Omid Akbari
Journal:  Int Arch Allergy Immunol       Date:  2009-09-29       Impact factor: 2.749

4.  Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling.

Authors:  Krista M Heinonen; Nadia Dubé; Annie Bourdeau; Wayne S Lapp; Michel L Tremblay
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

Review 5.  Barrier-tissue macrophages: functional adaptation to environmental challenges.

Authors:  Allan McI Mowat; Charlotte L Scott; Calum C Bain
Journal:  Nat Med       Date:  2017-11-07       Impact factor: 53.440

6.  Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.

Authors:  G P Shi; R A Bryant; R Riese; S Verhelst; C Driessen; Z Li; D Bromme; H L Ploegh; H A Chapman
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

7.  Interleukin 12 p40 production by barrier epithelial cells during airway inflammation.

Authors:  M J Walter; N Kajiwara; P Karanja; M Castro; M J Holtzman
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

Review 8.  Alveolar macrophages: plasticity in a tissue-specific context.

Authors:  Tracy Hussell; Thomas J Bell
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

9.  Benefits in the Macrophage Response Due to Graphene Oxide Reduction by Thermal Treatment.

Authors:  Mónica Cicuéndez; Laura Casarrubios; Nathalie Barroca; Daniela Silva; María José Feito; Rosalía Diez-Orejas; Paula A A P Marques; María Teresa Portolés
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

Review 10.  Diesel fumes and the rising prevalence of atopy: an urban legend?

Authors:  David Diaz-Sanchez; Lidia Proietti; Riccardo Polosa
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.